Abstract:Increased osteoclastic resorption and subsequent bone loss are common features of many debilitating diseases including osteoporosis, bone metastases, Paget's disease, and rheumatoid arthritis. While rapid progress has been made in elucidating the signaling pathways directing osteoclast differentiation and function, a comprehensive picture is far from complete. Here, we explore the role of the Ca(2+)-activated regulator calmodulin in osteoclastic differentiation, functional bone resorption, and apoptosis. During active bone resorption, calmodulin expression is increased, and calmodulin concentrates at the ruffled border, the organelle utilized for acid transport and bone dissolution. Pharmacologic inhibitors of calmodulin, several of which are already used clinically as anti-cancer and anti-psychotic agents, inhibit osteoclastic acid transport, suggesting their potential as bone-sparing drugs. Recent studies also implicate calmodulin in osteoclast apoptosis through a mechanism involving its direct interaction with the death receptor Fas. During osteoclastogenesis, RANKL-induction stimulates a rise in intracellular Ca2+, which in turn activates calmodulin and its downstream effectors. In particular, the Ca(2+)/calmodulin-dependent phosphatase calcineurin and its targets, the NFAT family of transcription factors, have been posited as the master regulators of osteoclastogenesis. However, recent in vivo and in vitro studies demonstrate that another Ca(2+)/calmodulin-regulated effector protein, CaMKII, is also involved. CaMKII(+/-) mutant mice have reduced osteoclast numbers, and CaMKII antagonists inhibit osteoclastogenesis in vitro. Furthermore, CaMKII is known to activate AP-1 transcription factors, which are also required for RANKL-induced osteoclast gene transcription, and recent findings suggest that CaMKII can down-regulate gp130, a cytokine receptor involved in bone remodeling and implicated in numerous osteo-articular diseases.

Role of Epithelial Sodium Channel in Rat Osteoclast Differentiation and Bone Resorption

Expression And Regulation Of Epithelial Sodium Channels (Enac) By Cgmp/Pkg In Bone And Osteoblasts

Role of Epithelium Sodium Channel in Bone Formation

Epithelial Sodium Channel Enhanced Osteogenesis Via Cgmp/pkgii/enac Signaling in Rat Osteoblast

Role of EphrinB2/EphB4 during alveolar bone resorption and remodeling

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

Estrogen Regulates the Expression and Activity of Epithelial Sodium Channel in Mouse Osteoblasts

Regulatory actions of 3',5'-cyclic adenosine monophosphate on osteoclast function: possible roles of Epac-mediated signaling

Acid-sensing Ion Channel 1a is Involved in Acid-Induced Osteoclastogenesis by Regulating Activation of the Transcription Factor NFATc1.

The role of calcium release activated calcium channels in osteoclast differentiation

Requirement of Calcium and Phosphate Ions in Expression of Sodium-Dependent Vitamin C Transporter 2 and Osteopontin in MC3T3-E1 Osteoblastic Cells.

Stimulation of Differentiation in Sodium-Dependent Vitamin C Transporter 2 Overexpressing MC3T3-E1 Osteoblasts

Amiloride Inhibits Osteoclastogenesis by Suppressing Nuclear Factor-Κb and Mitogen-Activated Protein Kinase Activity in Receptor Activator of Nuclear Factor-Κb-induced RAW264.7 Cells.

Anoctamin 1 controls bone resorption by coupling Cl− channel activation with RANKL-RANK signaling transduction

[Effects of Aldosterone on Osteoblast Proliferation, Differentiation and Osteogenic Gene Expressions in Vitro].

Regulation of epithelial sodium channel trafficking by ubiquitination.

Enac Activity is Regulated by Calpain-2 Proteolysis of Marcks Proteins

Cav1.3 Is Upregulated In Osteoporosis Rat Model And Promotes Osteoclast Differentiation From Preosteoclast Cell Line Raw264.7

Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival

The Ecto-Nucleotide Pyrophosphatase/phosphodiesterase 2 Promotes Early Osteoblast Differentiation and Mineralization in Stromal Stem Cells.